A groundbreaking study has identified how previously mysterious mutations in non-coding DNA contribute to kidney disease, ...
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene "silencer" that resides in junk DNA is directly sparing people from a devastating ...
Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...
Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...
Artificial intelligence is reshaping agriculture, and this year’s Lamont Rhodes Speaker Series will offer a closer look at ...
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
Swiss start-up Haya Therapeutics has formed a partnership with Eli Lilly – worth up to $1 billion – to look for new therapies for obesity in non-coding DNA. The biotech focuses on trawling the ...
Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is an urgent need for ...